CreditReports.dk
HomeScreen companies

Pharmovital ApS Financials, key figures and credit report

CVR number: 27206506 Established 2003 Industry: 46 Wholesale trade
Company contact details
Rosenkæret 11 B, 2860 Søborg ek@pharmovital.dk tel: 21719401
Gross profit 8 519.4 kDKK FY 2025 +258% vs 2024
EBIT 6 601.5 kDKK FY 2025 +750.5% vs 2024
Net debt -1 205.8 kDKK FY 2025 +13% vs 2024
Quick ratio 1.0 FY 2025 -0.1 vs 2024

Company information

Official name
Pharmovital ApS
Personnel
7 persons
Established
2003
Company form
Private limited company
Industry
  • Expand more icon46Wholesale trade

Data sources and methodology

The information about Pharmovital ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Pharmovital ApS

Pharmovital ApS (CVR number: 2720650-6) is a company from GLADSAXE. The company recorded a gross profit of 8519.4 kDKK in 2025. The operating profit was 6601.5 kDKK, while net earnings were 4924.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was 49 %, which can be considered excellent and Return on Equity (ROE) was 78.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 45.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Pharmovital ApS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit2 524.142 909.133 018.202 379.638 519.38
EBIT783.611 349.081 501.41776.176 601.49
Net earnings718.541 029.651 153.28586.154 924.77
Shareholders equity total2 349.312 578.973 482.253 818.408 743.17
Balance sheet total (assets)6 471.436 427.606 184.597 784.7119 146.55
Net debt-1 332.58-1 656.42-1 031.84-1 386.22-1 205.81
Profitability
EBIT-%
ROA13.2 %20.9 %23.8 %11.1 %49.0 %
ROE33.6 %41.8 %38.1 %16.1 %78.4 %
ROI36.5 %54.6 %49.4 %21.2 %105.1 %
Economic value added (EVA)676.56932.931 038.81423.954 948.53
Solvency
Equity ratio36.3 %40.1 %56.3 %49.1 %45.7 %
Gearing0.5 %0.9 %
Relative net indebtedness %
Liquidity
Quick ratio1.00.91.41.11.0
Current ratio1.61.72.32.01.8
Cash and cash equivalents1 343.881 656.421 062.041 386.221 205.81
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
49.0%
Rating 94/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
45.7%
Rating 37/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Pharmovital ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
Price shown at checkout

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated